BR112013006384A2 - processo para produção de fibrinogênio - Google Patents

processo para produção de fibrinogênio

Info

Publication number
BR112013006384A2
BR112013006384A2 BR112013006384A BR112013006384A BR112013006384A2 BR 112013006384 A2 BR112013006384 A2 BR 112013006384A2 BR 112013006384 A BR112013006384 A BR 112013006384A BR 112013006384 A BR112013006384 A BR 112013006384A BR 112013006384 A2 BR112013006384 A2 BR 112013006384A2
Authority
BR
Brazil
Prior art keywords
fibrinogen
fibrinogen production
production
fibrinopeptide
prion
Prior art date
Application number
BR112013006384A
Other languages
English (en)
Other versions
BR112013006384B1 (pt
Inventor
Schulz Petra
Pape Rainer
Gehringer Werner
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of BR112013006384A2 publication Critical patent/BR112013006384A2/pt
Publication of BR112013006384B1 publication Critical patent/BR112013006384B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

processo para produção de fibrinogênio. a presente invenção refere-se a um método ou processo para a fabricação de um vírus e príon exceto concentrado de fibrinogênio nativo de alta pureza e baixas quantidades de fibrinopeptide. a e fibronectina, cujo método compreende a cromatografia de etapa em um ânion forte enxertado com grupos amino terciários ou quartenários.
BR112013006384-0A 2010-09-20 2011-09-20 Processo para purificar fibrinogênio a partir de uma fonte contendo fibrinogênio, produto de fibrinogênio e uso de uma resina de troca aniônica BR112013006384B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10177640.9 2010-09-20
EP10177640 2010-09-20
US34471910P 2010-09-21 2010-09-21
US61/344,719 2010-09-21
PCT/EP2011/066293 WO2012038410A1 (en) 2010-09-20 2011-09-20 Process for production of fibrinogen

Publications (2)

Publication Number Publication Date
BR112013006384A2 true BR112013006384A2 (pt) 2017-07-18
BR112013006384B1 BR112013006384B1 (pt) 2021-12-07

Family

ID=43048945

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013006384-0A BR112013006384B1 (pt) 2010-09-20 2011-09-20 Processo para purificar fibrinogênio a partir de uma fonte contendo fibrinogênio, produto de fibrinogênio e uso de uma resina de troca aniônica

Country Status (12)

Country Link
US (2) US9371355B2 (pt)
EP (1) EP2619225B1 (pt)
JP (1) JP2013537215A (pt)
KR (1) KR20130112031A (pt)
CN (2) CN106046147B (pt)
AU (1) AU2011304364B2 (pt)
BR (1) BR112013006384B1 (pt)
CA (1) CA2809471A1 (pt)
ES (1) ES2586698T3 (pt)
MX (1) MX347190B (pt)
RU (1) RU2603103C2 (pt)
WO (1) WO2012038410A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9371355B2 (en) 2010-09-20 2016-06-21 Octapharma Ag Process for production of fibrinogen
AU2013231321B2 (en) 2012-03-13 2017-05-25 Octapharma Ag Improved process for production of fibrinogen and fibrinogen produced thereby
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
RU2556804C2 (ru) * 2013-12-17 2015-07-20 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата фибриногена
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
CA3003097A1 (en) * 2015-10-23 2017-04-27 Cerus Corporation Plasma compositions and methods of use thereof
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
CN107540743A (zh) * 2017-10-11 2018-01-05 南岳生物制药有限公司 一种双层析法制备人纤维蛋白原的方法
CN114901685A (zh) * 2019-12-10 2022-08-12 生物测试股份公司 用于制备纤维蛋白原制剂的方法
CA3224328A1 (en) 2021-08-13 2023-02-16 Biotest Ag Fibrinogen compositions and methods of preparation
CN113698470B (zh) * 2021-09-02 2023-03-17 成都蓉生药业有限责任公司 一种人纤维蛋白原的纯化方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
EP0748215B1 (en) 1994-02-17 2003-05-28 New York Blood Center, Inc. Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
ES2139227T5 (es) * 1994-07-14 2011-05-04 Caf-Dcf Département Central De Fractionnement De La Croix Rouge S.C.R.L. Concentrado de fibrinógeno obtenido de plasma sanguíneo, procedimiento e instalación para su preparación.
US6037457A (en) * 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
US7572769B2 (en) 1998-12-23 2009-08-11 Csl Behring Gmbh Fibrin adhesive granulate and method for its preparation
CA2362513C (en) * 1999-02-12 2011-04-26 Baxter Aktiengesellschaft A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
WO2001048016A1 (en) 1999-12-23 2001-07-05 Csl Limited Separation of fibrinogen from plasma proteases
EP1148063A1 (de) 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
IL136552A (en) * 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
WO2002095019A1 (en) * 2001-05-21 2002-11-28 Omrix Biopharmaceuticals S.A. Removal of plasmin(ogen) from protein solutions
DE10211632A1 (de) 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
AT501088A2 (de) 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
ES2214967B1 (es) 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US7968682B2 (en) 2006-12-12 2011-06-28 Oregon Health & Science University Degradation-resistant fibrinogen sealants
EP2293776B8 (de) 2008-06-23 2016-05-11 Bio-Products & Bio-Engineering Aktiengesellschaft Lagerstabiles, funktionell intaktes virus-inaktiviertes fibrinogen
CN101703763B (zh) * 2009-11-05 2012-07-11 绿十字(中国)生物制品有限公司 人纤维蛋白原的生产方法
US9371355B2 (en) 2010-09-20 2016-06-21 Octapharma Ag Process for production of fibrinogen
AU2013231321B2 (en) 2012-03-13 2017-05-25 Octapharma Ag Improved process for production of fibrinogen and fibrinogen produced thereby

Also Published As

Publication number Publication date
AU2011304364A1 (en) 2013-01-31
US20130274444A1 (en) 2013-10-17
KR20130112031A (ko) 2013-10-11
EP2619225B1 (en) 2016-06-15
AU2011304364B2 (en) 2015-07-09
WO2012038410A1 (en) 2012-03-29
BR112013006384B1 (pt) 2021-12-07
US20160264619A1 (en) 2016-09-15
CN106046147B (zh) 2019-11-19
ES2586698T3 (es) 2016-10-18
CN103328503A (zh) 2013-09-25
CA2809471A1 (en) 2012-03-29
RU2013118323A (ru) 2014-10-27
CN103328503B (zh) 2016-08-24
RU2603103C2 (ru) 2016-11-20
MX2013002657A (es) 2013-04-08
MX347190B (es) 2017-04-19
US9938318B2 (en) 2018-04-10
CN106046147A (zh) 2016-10-26
US9371355B2 (en) 2016-06-21
EP2619225A1 (en) 2013-07-31
JP2013537215A (ja) 2013-09-30

Similar Documents

Publication Publication Date Title
BR112013006384A2 (pt) processo para produção de fibrinogênio
BR112015013129A2 (pt) métodos e materiais para a biossíntese de compostos mogrosida
BR112015004467A2 (pt) método para controlar a heterogeneidade de proteínas
BR112014012275A2 (pt) purificação de proteína com a utilização de tampão bis-tris
BR112013032619A2 (pt) métodos e composições relacionados com reciclagem dos resíduos de polímero
BR112015006874A2 (pt) ligantes de rig-i inovadores e métodos para produzir os mesmos
BR112018077067A2 (pt) processo para preparar um composto.
BR112016020517A2 (pt) método de produção de lipídeo através da utilização de ss-cetoacil-acp sintase
BR112016006606A2 (pt) Molécula de ácido nucléico recombinante, molécula de aminoácido recombinante, construção de expressão recombinante, vetor recombinante, micro-organismo recombinante, composição, método de produção de aminoácidos, uso de uma molécula de ácido nucléico e processo de produção fermentativa
BR112015006393A2 (pt) método para produzir um produto de tecido, produto de tecido produzido por um processo, e método de tratamento
MX356454B (es) Una formulacion enzimatica liquida y un proceso para su preparacion.
BR112017025923A2 (pt) molécula de ácido nucleico recombinante, molécula de aminoácido recombinante, construto de expressão recombinante, vetor recombinante, micro-organismo recombinante, composição, métodos para produção de um micro-organismo recombinante e para cultivo e crescimento de um micro-organismo geneticamente modificado, uso de uma molécula de ácido nucleico recombinante, e, processo para produção fermentativa de um composto.
EA201491564A1 (ru) Осаждение фракции i-iv-1 иммуноглобулинов из плазмы
MD20150109A2 (ro) Construcţii proteice mitocondriale şi utilizările acestora
MX2013009855A (es) Plantas que tienen rasgos relacionados con rendimiento mejorado y metodos para producir los mismos.
BR112019003403A2 (pt) compósito, processo para a preparação de um compósito, e, artigo moldado.
BR112013025244A2 (pt) composição de aglutinante aquosa, uso de uma composição de aglutinante aquosa, processo para a produção de um artigo moldado, artigo moldado, uso de um artigo moldado, e, membrana de telhado betumizada
BR112019001605A2 (pt) processo para a preparação de proteína ou peptídeo
BR112018075449A2 (pt) compósito, processo para preparação de um compósito, e, artigo moldado.
MY169049A (en) Microorganisms for producing putrescine and process for producing putrescine using them
EP4067485A3 (en) Lipase variants and polynucleotides encoding same
BR112017011275A2 (pt) composição, e, processo para a produção de xarope de glicose.
BR112012026157A2 (pt) processo para preparar ditiina-tetracarboximidas.
BR112012026705A2 (pt) método para produzir um produto natural fermentado.
EA200900984A1 (ru) Улучшение клеточного роста

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09Y Publication of grant cancelled [chapter 9.1.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 9.1 NA RPI NO 2635 DE 06/07/2021 POR TER SIDO INDEVIDA.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/09/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.